2025-05-02 11:19:19
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
IOL Chemicals and Pharmaceuticals Ltd Q1FY22 PAT declines to Rs. 67 crore
Posted On : 2021-08-15 19:19:38( TIMEZONE : IST )
IOL Chemicals & Pharmaceuticals Ltd has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.524.23 crores during the period ended June 30, 2021 as compared to Rs.466.59 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.67 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.75.25 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.11.41 for the period ended June 30, 2021 as compared to Rs.12.76 for the period ended March 31, 2021.
| Financials | Q1 FY2021-22 | Q4 FY20-21 | % Change |
| Total Income | ₹ 524.23 crs | ₹ 466.59 crs |  12.35% |
| Net Profit | ₹ 67 crs | ₹ 75.25 crs |  -10.96% |
| EPS | ₹ 11.41 | ₹ 12.76 | -10.58% |
Financial Results (Q1 FY 2021-22) - YoY Comparison
The company has reported total income of Rs.524.23 crores during the period ended June 30, 2021 as compared to Rs.465.91 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.67 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.127.54 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.11.41 for the period ended June 30, 2021 as compared to Rs.22.30 for the period ended June 30, 2020.
| Financials | Q1 FY2021-22 | Q1 FY2020-21 | % Change |
| Total Income | ₹ 524.23 crs | ₹ 465.91 crs | 12.52% |
| Net Profit | ₹ 67 crs | ₹ 127.54 crs | -47.47% |
| EPS | ₹ 11.41 | ₹ 22.30 | -48.83% |
Dr Sanjay Chaturvedi, Chief Executive Officer said "During the quarter ended June 2021, the Company's performance has been satisfactory in spite of difficult operating conditions faced by the Company during surged situation of Covid-19 pandemic. The Chemicals segment performed very well during the quarter both in terms of top line and bottom line.
He also added, the Company completed the installation of new manufacturing facilities 'Unit-10' to manufacture multiple Pharma (API's) products including Fenofibrate, Lamotrigine and Ursodeoxycholic Acid (UDCA) to cater the growing demand.
Talking about future projects, he added that the installation of new manufacturing facilities 'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is slightly delayed of its schedule due to 2nd wave of Covid-19 and expected to complete in 3rd quarter of FY22 without any cost overrun.
Shares of IOL Chemicals & Pharmaceuticals Ltd was last trading in BSE at Rs. 657.85 as compared to the previous close of Rs. 655.2. The total number of shares traded during the day was 59330 in over 1866 trades.
The stock hit an intraday high of Rs. 669 and intraday low of 655.05. The net turnover during the day was Rs. 39233420.
